The balance sheet strengthened as equity grew 56% to $12.5B and D/E fell from 0.62 to 0.33, while cash of $5.6B and a current ratio of 2.63 provide a robust liquidity buffer.
Lam Research Corporation (LRCX) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | Jun'26 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 |
|---|
| Total Current Assets | 15.61B | 14.52B | 12.88B | 13.23B | 12.29B | 11.65B | 10.85B | 8.56B | 9.15B | 9.14B | 9.21B | 6.27B | 4.78B | 3.79B | 4.42B | 3.28B | 1.76B | 1.2B | 1.92B | 1.42B | 1.71B | 1.24B | 896.39M | 872.78M | 1.36B | 1.58B | 1.02B | 738.87M | 897.09M | 746.04M |
| Cash & Short-Term Investments | 5.58B | 6.39B | 5.85B | 5.37B | 3.66B | 5.73B | 6.71B | 5.43B | 4.95B | 6.04B | 6.83B | 4.08B | 3.07B | 2.5B | 2.86B | 2.12B | 826.46M | 579.39M | 1.06B | 670.69M | 1.05B | 809.25M | 429.47M | 507.41M | 874.21M | 864.56M | 371.72M | 311.8M | 397.16M | 164.25M |
| Cash Only | 5.58B | 6.39B | 5.85B | 5.34B | 3.52B | 4.42B | 4.92B | 3.66B | 4.51B | 2.38B | 5.04B | 1.5B | 1.45B | 1.16B | 1.56B | 1.49B | 545.77M | 374.17M | 732.54M | 573.97M | 910.82M | 482.25M | 163.4M | 167.34M | 172.43M | 221.66M | 70.06M | 37.97M | 13.51M | 125.72M |
| Short-Term Investments | 0 | 0 | 0 | 37.64M | 135.73M | 1.31B | 1.8B | 1.77B | 437.34M | 3.66B | 1.79B | 2.57B | 1.61B | 1.33B | 1.3B | 630.12M | 280.69M | 205.22M | 326.2M | 96.72M | 139.52M | 327M | 266.07M | 340.07M | 701.77M | 642.9M | 301.67M | 273.84M | 383.65M | 38.52M |
| Accounts Receivable | 5.34B | 3.38B | 2.52B | 2.82B | 4.31B | 3.03B | 2.1B | 1.46B | 2.18B | 1.67B | 1.26B | 1.09B | 800.62M | 602.62M | 765.82M | 590.57M | 499.89M | 253.59M | 412.36M | 410.01M | 407.35M | 232M | 245.51M | 107.6M | 132.11M | 248.91M | 323.94M | 170.53M | 176.03M | 223.12M |
| Days Sales Outstanding | 83.89 | 66.88 | 61.69 | 59.14 | 91.4 | 75.53 | 76.2 | 55.03 | 71.73 | 76.22 | 78.27 | 75.9 | 63.43 | 61.12 | 104.88 | 66.58 | 85.51 | 82.94 | 60.81 | 58.31 | 90.54 | 56.36 | 95.74 | 52 | 51.13 | 59.78 | 96.07 | 96.06 | 61.04 | 81.24 |
| Inventory | 4.28B | 4.31B | 4.22B | 4.82B | 3.97B | 2.69B | 1.9B | 1.54B | 1.88B | 1.23B | 971.91M | 943.35M | 740.5M | 559.32M | 632.85M | 396.61M | 318.48M | 233.41M | 282.22M | 235.43M | 168.71M | 110.05M | 108.25M | 112.02M | 180.8M | 284.76M | 227.17M | 183.72M | 220.61M | 253.76M |
| Days Inventory Outstanding | 135.63 | 166.28 | 196.06 | 182.14 | 154.75 | 125.51 | 127.58 | 106.16 | 115.83 | 102.04 | 108.59 | 115.74 | 103.96 | 92.97 | 146.09 | 83.17 | 99.88 | 117.15 | 79.15 | 68.12 | 75.54 | 54.36 | 78.26 | 90.57 | 97.47 | 120.53 | 119.97 | 161.74 | 124.55 | 134.34 |
| Other Current Assets | 415.74M | 440.27M | 298.19M | -37.64M | 0 | 0 | 0 | 1.37M | 7.69M | 8.27M | 2.17M | 0 | 0 | 0 | 47.78M | 81.96M | 46.16M | 27.73M | 96.75M | 61.73M | 53.63M | 76.66M | 102.73M | 133.07M | 125.23M | 157.53M | 76.51M | 55.65M | 77.48M | 91.82M |
| Total Non-Current Assets | 7.92B | 6.83B | 5.86B | 5.55B | 4.91B | 4.24B | 3.71B | 3.44B | 3.33B | 2.98B | 3.06B | 3.09B | 3.21B | 3.46B | 3.59B | 780.6M | 730.73M | 756.04M | 889.05M | 685.24M | 606.98M | 203.98M | 302.24M | 325.5M | 276.87M | 295.17M | 223.5M | 240.58M | 253.68M | 219.41M |
| Property, Plant & Equipment | 2.96B | 2.43B | 2.15B | 1.86B | 1.65B | 1.48B | 1.25B | 1.06B | 902.55M | 685.6M | 639.61M | 621.42M | 543.5M | 603.91M | 584.6M | 270.46M | 200.34M | 215.67M | 235.74M | 113.72M | 49.89M | 41.08M | 42.44M | 48.77M | 67.5M | 126.53M | 119.19M | 103.34M | 144.25M | 184.5M |
| Fixed Asset Turnover | 7.86x | 7.59x | 6.92x | 9.39x | 10.46x | 9.90x | 8.06x | 9.12x | 12.27x | 11.69x | 9.20x | 8.46x | 8.48x | 5.96x | 4.56x | 11.97x | 10.65x | 5.17x | 10.50x | 22.57x | 32.91x | 36.57x | 22.05x | 15.49x | 13.97x | 12.01x | 10.33x | 6.27x | 7.30x | 5.43x |
| Goodwill | 0 | 1.63B | 1.63B | 1.62B | 1.52B | 1.49B | 1.48B | 1.48B | 1.48B | 1.39B | 1.39B | 1.39B | 1.47B | 1.45B | 1.45B | 169.18M | 169.18M | 169.18M | 281.3M | 59.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.9B | 182.2M | 138.54M | 168.45M | 101.85M | 132.37M | 168.53M | 216.95M | 317.84M | 411M | 564.92M | 728.14M | 894.08M | 1.07B | 1.24B | 47.43M | 67.72M | 91.61M | 121.89M | 70.91M | 14.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 17M | 2.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 165.26M | 165.23M | 178.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 334K | 0 | 0 | 0 |
| Other Non-Current Assets | 3.07B | 2.57B | 1.94B | 1.91B | 1.65B | 1.14B | 806.46M | 937.01M | 880.58M | 754.21M | 465.81M | 356.73M | 305.85M | 298.36M | 270.44M | 124.38M | 102.04M | 84.14M | 230.33M | 413.45M | 503.91M | 119.67M | 153.29M | 189.7M | 123.14M | 148.87M | 91.99M | 85.5M | 83.03M | 34.91M |
| Total Assets | 23.53B | 21.35B | 18.74B | 18.78B | 17.2B | 15.89B | 14.56B | 12B | 12.48B | 12.12B | 12.27B | 9.36B | 7.99B | 7.25B | 8B | 4.06B | 2.49B | 1.95B | 2.81B | 2.1B | 2.33B | 1.45B | 1.2B | 1.2B | 1.63B | 1.87B | 1.24B | 979.45M | 1.15B | 965.45M |
| Asset Turnover | 0.99x | 0.86x | 0.80x | 0.93x | 1.00x | 0.92x | 0.69x | 0.80x | 0.89x | 0.66x | 0.48x | 0.56x | 0.58x | 0.50x | 0.33x | 0.80x | 0.86x | 0.57x | 0.88x | 1.22x | 0.71x | 1.04x | 0.78x | 0.63x | 0.58x | 0.81x | 0.99x | 0.66x | 0.91x | 1.04x |
| Asset Growth % | 10.23% | 13.87% | -0.2% | 9.22% | 8.2% | 9.16% | 21.31% | -3.83% | 2.94% | -1.21% | 31.04% | 17.16% | 10.25% | -9.42% | 97.29% | 63.12% | 27.44% | -30.46% | 33.55% | -9.7% | 60.64% | 20.87% | 0.03% | -26.59% | -12.79% | 50.36% | 27.1% | -14.89% | 19.2% | -0.4% |
| Total Current Liabilities | 5.94B | 6.57B | 4.34B | 4.18B | 4.56B | 3.53B | 3.16B | 2.37B | 3.15B | 2.95B | 2.42B | 2.63B | 1.58B | 1.4B | 1.43B | 680.76M | 558.66M | 382.08M | 637.68M | 672.8M | 567.65M | 379.13M | 376.61M | 216.98M | 597.54M | 499.68M | 287.76M | 244M | 293.51M | 329.11M |
| Accounts Payable | 0 | 854.21M | 613.97M | 470.7M | 1.01B | 829.71M | 592.39M | 376.56M | 510.98M | 464.64M | 348.2M | 300.2M | 223.51M | 200.25M | 258.78M | 163.54M | 121.1M | 49.61M | 89.16M | 117.62M | 108.5M | 60.22M | 93.39M | 35.52M | 59.81M | 56.57M | 76.65M | 51.22M | 67.7M | 113.66M |
| Days Payables Outstanding | - | 32.97 | 28.54 | 17.8 | 39.45 | 38.72 | 39.78 | 25.96 | 31.55 | 38.45 | 38.9 | 36.83 | 31.38 | 33.29 | 59.74 | 34.3 | 37.98 | 24.9 | 25 | 34.03 | 48.58 | 29.74 | 67.52 | 28.72 | 32.24 | 23.94 | 40.48 | 45.09 | 38.22 | 60.17 |
| Short-Term Debt | 0 | 749.67M | 501.32M | 421K | 0 | 0 | 836.11M | 667.13M | 610.03M | 908.44M | 947.73M | 1.36B | 518.27M | 514.65M | 511.14M | 4.78M | 4.97M | 5.35M | 30.21M | 0 | 0 | 0 | 2.5M | 5.01M | 315.29M | 8.96M | 7.63M | 20.57M | 17.36M | 55.84M |
| Deferred Revenue (Current) | 0 | 2.57B | 1.42B | 1.7B | 1.57B | 967.33M | 457.52M | 381.32M | 720.09M | 607.67M | 349.2M | 322.07M | 235.92M | 225.04M | 164.83M | 153.68M | 123.19M | 45.79M | 128.25M | 190.88M | 140.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.93B | 1.48B | 1.35B | 1.32B | 1.3B | 728.96M | 520.24M | 464.02M | 698.95M | 609.34M | 431.85M | 407.73M | 379.38M | 307.05M | 338.15M | 247.26M | 164.58M | 0 | 0 | 207.21M | 201.36M | 89.71M | 108.37M | 45.31M | 63.44M | 250.83M | 0 | 0 | 0 | 0 |
| Current Ratio | 2.63x | 2.21x | 2.97x | 3.16x | 2.69x | 3.30x | 3.43x | 3.61x | 2.90x | 3.10x | 3.81x | 2.38x | 3.02x | 2.70x | 3.09x | 4.81x | 3.14x | 3.13x | 3.01x | 2.11x | 3.01x | 3.28x | 2.38x | 4.02x | 2.27x | 3.16x | 3.55x | 3.03x | 3.06x | 2.27x |
| Quick Ratio | 1.91x | 1.55x | 2.00x | 2.01x | 1.82x | 2.54x | 2.83x | 2.96x | 2.31x | 2.68x | 3.41x | 2.02x | 2.56x | 2.30x | 2.65x | 4.23x | 2.57x | 2.52x | 2.56x | 1.76x | 2.71x | 2.99x | 2.09x | 3.51x | 1.97x | 2.59x | 2.76x | 2.28x | 2.30x | 1.50x |
| Cash Conversion Cycle | - | 200.19 | 229.21 | 223.47 | 206.69 | 162.31 | 164 | 135.24 | 156.02 | 139.8 | 147.95 | 154.8 | 136.01 | 120.8 | 191.23 | 115.45 | 147.41 | 175.2 | 114.96 | 92.4 | 117.5 | 80.98 | 106.48 | 113.86 | 116.36 | 156.37 | 175.56 | 212.71 | 147.37 | 155.41 |
| Total Non-Current Liabilities | 5.12B | 4.92B | 5.87B | 6.39B | 6.35B | 6.34B | 6.21B | 4.91B | 2.75B | 2.19B | 3.74B | 1.39B | 1.2B | 1.17B | 1.26B | 903.26M | 160.6M | 158.02M | 385.13M | 252.49M | 350.97M | 2.79M | 9.55M | 332.21M | 359.69M | 659.72M | 321.66M | 326.5M | 334.17M | 45.71M |
| Long-Term Debt | 3.73B | 3.72B | 4.47B | 4.96B | 4.96B | 4.95B | 4.96B | 3.82B | 1.81B | 1.78B | 3.38B | 1B | 817.2M | 789.26M | 761.78M | 738.49M | 17.64M | 40.89M | 276.12M | 250M | 350M | 2.79M | 9.55M | 332.21M | 359.69M | 659.72M | 321.66M | 326.5M | 334.17M | 45.71M |
| Capital Lease Obligations | 0 | 203.84M | 12.47M | 38.24M | 35.99M | 29.4M | 11.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 103M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.39B | 991.68M | 1.39B | 1.38B | 1.35B | 1.35B | 1.24B | 1.08B | 942.57M | 400.36M | 366.08M | 386.95M | 381.02M | 380.79M | 493.82M | 164.78M | 142.96M | 14.13M | 109.01M | 2.49M | 969K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 11.06B | 11.48B | 10.21B | 10.57B | 10.92B | 9.86B | 9.38B | 7.28B | 5.9B | 5.14B | 6.16B | 4.02B | 2.78B | 2.57B | 2.68B | 1.58B | 719.26M | 498.78M | 1.02B | 925.28M | 918.62M | 381.92M | 386.16M | 549.19M | 957.24M | 1.16B | 609.41M | 570.5M | 627.68M | 374.81M |
| Total Debt | 3.73B | 4.76B | 4.98B | 5.01B | 5.01B | 5B | 5.81B | 4.49B | 2.42B | 2.69B | 4.33B | 2.36B | 1.34B | 1.3B | 1.27B | 743.27M | 22.61M | 46.23M | 306.33M | 250M | 350M | 2.79M | 12.05M | 337.22M | 674.98M | 668.68M | 329.29M | 347.07M | 351.54M | 101.55M |
| Net Debt | -1.84B | -1.63B | -864.52M | -325.51M | 1.48B | 576.8M | 895.55M | 831.68M | -2.1B | 315.88M | -713.46M | 859.49M | -117.21M | 141.44M | -291.83M | -748.86M | -523.15M | -327.93M | -426.21M | -323.97M | -560.82M | -479.46M | -151.35M | 169.88M | 502.55M | 447.02M | 259.23M | 309.1M | 338.03M | -24.18M |
| Debt / Equity | 0.30x | 0.48x | 0.58x | 0.61x | 0.80x | 0.83x | 1.12x | 0.95x | 0.37x | 0.39x | 0.71x | 0.44x | 0.26x | 0.28x | 0.24x | 0.30x | 0.01x | 0.03x | 0.17x | 0.21x | 0.25x | 0.00x | 0.01x | 0.52x | 1.00x | 0.94x | 0.52x | 0.85x | 0.67x | 0.17x |
| Debt / EBITDA | 0.43x | 0.76x | 1.08x | 0.91x | 0.88x | 1.04x | 1.97x | 1.62x | 0.68x | 1.22x | 3.17x | 2.21x | 1.38x | 3.09x | 3.76x | 0.85x | 0.05x | - | 0.54x | 0.31x | 0.82x | 0.01x | 0.09x | 8.52x | - | 2.73x | 1.19x | - | - | - |
| Net Debt / EBITDA | -0.21x | -0.26x | -0.19x | -0.06x | 0.26x | 0.12x | 0.30x | 0.30x | -0.59x | 0.14x | -0.52x | 0.81x | -0.12x | 0.34x | -0.86x | -0.85x | -1.05x | - | -0.76x | -0.40x | -1.31x | -1.15x | -1.07x | 4.29x | - | 1.82x | 0.94x | - | - | - |
| Interest Coverage | - | 33.43x | 24.54x | 28.40x | 29.11x | 21.95x | 15.51x | 21.86x | 33.36x | 16.39x | 8.12x | 11.05x | 12.73x | 2.10x | 6.25x | 149.86x | 433.74x | -39.49x | 46.52x | 48.58x | 421.85x | 283.46x | - | - | - | - | - | - | - | - |
| Total Equity | 12.47B | 9.86B | 8.54B | 8.21B | 6.28B | 6.03B | 5.18B | 4.72B | 6.58B | 6.99B | 6.1B | 5.34B | 5.21B | 4.68B | 5.32B | 2.47B | 1.77B | 1.45B | 1.78B | 1.18B | 1.41B | 1.07B | 812.47M | 649.08M | 675.06M | 712.37M | 635.42M | 408.96M | 523.09M | 590.64M |
| Equity Growth % | 26.46% | 15.48% | 4.01% | 30.77% | 4.17% | 16.28% | 9.74% | -28.22% | -5.83% | 14.51% | 14.17% | 2.53% | 11.49% | -12.14% | 115.48% | 39.69% | 21.68% | -18.55% | 51.65% | -16.5% | 32.04% | 31.32% | 25.17% | -3.85% | -5.24% | 12.11% | 55.38% | -21.82% | -11.44% | -3.14% |
| Book Value per Share | 9.89 | 7.64 | 6.47 | 6.04 | 4.46 | 4.15 | 3.48 | 2.95 | 3.64 | 3.80 | 3.48 | 3.02 | 2.99 | 2.70 | 4.25 | 1.98 | 1.38 | 1.16 | 1.41 | 0.83 | 0.98 | 0.75 | 0.53 | 0.51 | 0.53 | 0.54 | 0.44 | 0.35 | 0.46 | 0.64 |
| Total Shareholders' Equity | 12.47B | 9.86B | 8.54B | 8.21B | 6.28B | 6.03B | 5.18B | 4.72B | 6.58B | 6.99B | 6.1B | 5.34B | 5.21B | 4.68B | 5.32B | 2.47B | 1.77B | 1.45B | 1.78B | 1.18B | 1.41B | 1.07B | 812.47M | 649.08M | 675.06M | 712.37M | 635.42M | 408.96M | 523.09M | 590.64M |
| Common Stock | 0 | 1.27M | 130K | 133K | 137K | 143K | 145K | 144K | 157K | 162K | 160K | 159K | 162K | 163K | 187K | 124K | 126K | 127K | 125K | 124K | 142K | 137K | 135K | 127K | 128K | 125K | 124K | 39K | 38K | 31K |
| Retained Earnings | 0 | 28.99B | 24.81B | 22.03B | 18.45B | 14.68B | 11.52B | 9.93B | 8.26B | 6.25B | 4.82B | 4.1B | 3.58B | 2.97B | 2.86B | 2.69B | 1.97B | 1.62B | 1.93B | 1.47B | 784.42M | 520.16M | 221.12M | 143.82M | 157.04M | 254.28M | 227.29M | 28.83M | 141.75M | 277.96M |
| Treasury Stock | 0 | -27.76B | -24.37B | -21.53B | -19.48B | -15.65B | -12.95B | -11.6B | -7.85B | -5.22B | -4.43B | -4.3B | -3.76B | -3.54B | -2.64B | -1.76B | -1.58B | -1.5B | -1.49B | -1.48B | -416.45M | -186.06M | -19.74M | -38.67M | -9.1M | -21.9M | -26.44M | -8.43M | 0 | 0 |
| Accumulated OCI | 0 | -62.42M | -130.43M | -100.71M | -109.98M | -64.13M | -94.21M | -64.03M | -57.45M | -61.7M | -69.33M | -57.8M | -28.66M | -28.69M | -33.82M | 9.76M | -69.85M | -52.82M | 10.62M | -4.3M | -11.21M | -12.01M | -17.12M | -16.46M | -15.24M | -18.2M | -7.5M | -432K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying LRCX stock.
As of 2026, Lam Research Corporation (LRCX) had total assets of $23.53B including $15.61B in current assets.
Lam Research Corporation (LRCX) carries total debt of $3.73B, offset by $5.58B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Lam Research Corporation (LRCX) has total shareholders' equity (book value) of $12.47B ($9.89 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Lam Research Corporation (LRCX) reported a current ratio of 2.63x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
China concentration and EPS miss
Metrics are mathematically derived from official filings.
Balance Sheet Strengthening on AI Demand
Total assets grew from $18.3B to $23.5B over ten quarters, with equity expanding 56% to $12.5B, as per reported balance sheet data, indicating a strengthening financial position.
The sequential increase in total assets, particularly in cash and PPE, reflects reinvestment in capacity to meet AI-driven demand. Equity growth outpaced asset growth, suggesting retained earnings are accumulating faster than debt, which may signal improving financial flexibility. The trend appears sustainable if AI demand persists, but investors should monitor whether asset growth translates into productive capacity.
Leverage Declining Despite Higher Debt
Total debt rose to $4.1B in 2026Q4 from $5.0B in 2024Q3, yet D/E fell from 0.62 to 0.33, as per financial statements, indicating equity growth is outpacing debt accumulation.
The absolute debt level has decreased slightly, but the more significant driver is the 56% increase in equity, which has halved the leverage ratio. This suggests a conservative capital structure that may provide ample headroom for future borrowing if needed. The low D/E relative to peers like KLAC (0.93) implies LRCX has strategic flexibility, though the recent EPS miss may warrant caution in assuming aggressive debt-funded growth.
Asset Mix Reflects Capital-Light Model
PPE net of $3.0B represents only 12.8% of total assets, while goodwill of $1.9B is stable, as per balance sheet data, indicating a capital-light business with limited intangible risk.
The relatively small PPE footprint underscores the asset-light nature of LRCX's manufacturing model, which relies on outsourcing and assembly rather than heavy vertical integration. Goodwill has remained flat, suggesting no major acquisitions, and the absence of impairment charges implies the existing goodwill is not at risk. This asset mix supports high returns on invested capital, but investors should note that the company's competitive advantage lies in intellectual property and process know-how, not physical assets.
Retained Earnings Drive Equity Expansion
Retained earnings grew from $24.1B to $35.0B over ten quarters, a 45% increase, as per reported figures, while equity rose to $12.5B, indicating strong internal capital generation.
The substantial growth in retained earnings, despite aggressive share repurchases and dividends, highlights the company's ability to generate excess cash. The equity base is now larger than total liabilities, providing a cushion against cyclical downturns. However, the pace of buybacks may have contributed to the EPS miss if repurchases were executed at elevated prices, though the balance sheet itself remains solid.
Liquidity Buffer Remains Robust
Current ratio improved to 2.63 in 2026Q4 from 2.82 in 2024Q3, with cash of $5.6B, as per balance sheet data, providing a strong buffer against operational shocks.
The current ratio, while slightly lower than the 2024Q3 peak, remains well above 2.0, indicating ample short-term liquidity. Cash balances have been maintained above $5B, even after returning $2.1B to shareholders in 2026Q4, per cash flow data. This suggests the company can fund its operations and capital returns without straining liquidity, though the working capital swings noted in the cash flow analysis may require monitoring.
Deferred Revenue Signals Demand Visibility
Deferred revenue rose to $2.3B in 2026Q4 from $1.6B in 2024Q3, a 44% increase, as per balance sheet data, indicating strong customer prepayments and forward demand.
The growth in deferred revenue suggests customers are committing to tool purchases ahead of delivery, which may provide visibility into near-term revenue. However, the increase could also reflect longer acceptance cycles, as noted in the revenue recognition nuances. Investors should monitor whether deferred revenue converts to recognized revenue efficiently, as a buildup may indicate shipment delays or customer acceptance issues.